QPCT and early-onset autosomal dominant Alzheimer disease: Bioactive compounds from microalgae are also being explored as potential anti-Alzheimer’s disease agents by inhibiting glutaminyl cyclase (QC), a key enzyme involved in the disease’s onset [33], astaxanthin microencapsulated in Spirulina has demonstrated neuroprotective benefits in rats [34].